UMIP PREMIER FUND: LOGO
UMIP PREMIER FUND: Home UMIP PREMIER FUND: Fund UMIP PREMIER FUND: The Team UMIP PREMIER FUND: Portfolio UMIP PREMIER FUND: News & Events UMIP PREMIER FUND: Submit a business plan UMIP PREMIER FUND: Contact us
 

Latest News:

... Latest Story

Further Information:

UMIP - Case Studies of Spin-outs
... Download PDF
(940k)

 

UPF Masterclasses:

December 1st 2009

    More information

March 31st 2009

    More information

November 25th 2008

..  More information

UPF Masterclass Hall of Fame

05/08/10

MTI Investee APATECH wins prestigious Large Deal of the Year award at 2010 Vitesse Media Awards

24/05/10

UPF increases investment in Arvia Technology

12/05/10

UPF Invests in University of Manchester med-tech spin-out, BiOxyDyn

28/04/10

UPF leads £1.15m investment round in PowerOasis

01/03/10

MTI has largest ever exit by selling investee company APATECH for $330m

22/02/10

Ai2 Limited announce appointment of new CEO

18/02/10

Nano ePrint partners with Novalia to deliver printed electronic greeting cards for Tigerprint

03/02/10

UPF leads £2m investment round to help bring new pest control products to market

23/01/10

UPF investee MYCONOSTICA launches Pneumocystis diagnostic kit in Europe and Canada

22/01/10

UPF invests £250,000 in Ai2

14/01/10

NWDA awards £9m Transitional fund to MTI

30/11/09

MTI & NWDA boosts Manchester hi-tech spin-out

13/11/09

Award winning week for the UMIP Premier Fund’s investments

26/10/09

LEIN DIAGNOSTICS secures £1 million funding from UPF and NESTA to develop pain-free medical diagnostics technology

(Download PDF 51kb)

22/10/09

UPF Invests half a million in CABLESENSE - North West hi-tech specialists back Lancaster busines

(Download PDF 30kb)

07/09/09

UPF Investee MYCONOSTICA attracts £1.7m in Series D financing to progress its fungal diagnostics

05/09/09

UPF Investee ARVIA TECHNOLOGY named in Global Cleantech 100 company listing

05/09/09

‘Proud parents’ celebrate 25th birthday of breakthrough technology

09/07/09

UPF Investee ARVIA TECHNOLOGY wins major North West Innovation award

03/07/09

Paul Strzelecki appointed Honorary Visiting Professor at The University of Manchester, (School of Electrical and Electronic Engineering)

29/06/09

UMIP scoops Business Impact Award

19/03/09

Breakthrough research by University student could speed up the recovery of injured athletes.

News from 2008>

UPF investee Myconostica Ltd, a UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces that it has launched a new version of its of MycAssay™ Pneumocystis product in the European Community and Canada.

MycAssay™ Pneumocystis is a molecular diagnostic test for the detection of Pneumocystis jirovecii DNA in lower respiratory tract samples. The new kit has improved clinical performance and increased analytical sensitivity. The kit is designed to be used by qualified laboratory professionals; the results provided by MycAssay™ Pneumocystis aid physicians to make a diagnosis in patients suspected of having an infection caused by Pneumocystis jirovecii.

When MycAssay™ Pneumocystis is used in conjunction with Myconostica’s fungal DNA extraction system, MycXtra®, a result
can be obtained within 3 hours of sample receipt. MycAssay™ Pneumocystis provides rapid and accurate results to physicians, enabling appropriate drug treatments to be administered thereby improving patient outcomes.

Myconostica also announces that it has signed an agreement with Bactus AB (Bactus AB, Lunastigen 3, SE 141 44 Huddinge, Sweden, www.bactus.se, contact: Jan Skansen) to act as the exclusive distributor of its products in Sweden and Finland.

Dr. John Thornback, Myconostica’s Chief Business Officer, said "We have a programme of constant improvement and standardisation of our assays and, in addition to improved clinical performance of the new kit, both MycAssay™ Aspergillus
and MycAssay™ Pneumocystis now have identical PCR component volumes, sample volumes, pathogen and internal control fluorophores, and similar run parameters"

www.myconostica.co.uk